3DBio is the only clinical-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants
SCIENCE & TECHNOLOGY
Living Tissue Implants
3DBio’s pioneering approach develops living tissue implants with structural and functional integrity with a four-part technology platform, including: novel and proprietary 3D-bioprinter (GMPrint™), bio-ink (ColVivo™), specialized cell culture system, and implantable protective shell (Overshell Technology)
PATIENTS
The Future is Now
At 3DBio, we know 3D-printing of human tissues and organs is achievable. We know because we’ve done it. Our first patient-matched, patient tissue-derived product, AuriNovo™, is being evaluated in a clinical trial in adults and children
INVESTORS
Corporate Profile
3DBio is a clinical-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and materials technologies to deliver safe, functional and personalized living tissues and organs, engineered on-demand for patients
